376 related articles for article (PubMed ID: 36834917)
1. Enhancing Skin Cancer Immunotheranostics and Precision Medicine through Functionalized Nanomodulators and Nanosensors: Recent Development and Prospects.
Farhana A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834917
[TBL] [Abstract][Full Text] [Related]
2. Recent advancements in immunotherapy of melanoma using nanotechnology-based strategies.
Bahreyni A; Mohamud Y; Luo H
Biomed Pharmacother; 2023 Mar; 159():114243. PubMed ID: 36641926
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers.
Inthagard J; Edwards J; Roseweir AK
Clin Sci (Lond); 2019 Jan; 133(2):181-193. PubMed ID: 30659159
[TBL] [Abstract][Full Text] [Related]
4. [A malignus melanoma immunterápiájának lehetoségei].
Ladányi A
Magy Onkol; 2003; 47(1):113-7. PubMed ID: 12704464
[TBL] [Abstract][Full Text] [Related]
5. Personalized Immuno-Oncology.
Jain KK
Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for cutaneous malignancy.
Ibrahim SF; Sambandan D; Ratner D
Dermatol Surg; 2011 Oct; 37(10):1377-93. PubMed ID: 21806705
[TBL] [Abstract][Full Text] [Related]
7. Current status and future direction in the management of malignant melanoma.
Gladfelter P; Darwish NHE; Mousa SA
Melanoma Res; 2017 Oct; 27(5):403-410. PubMed ID: 28800028
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in localized immunotherapy of skin cancers.
Russo I; Sernicola A; Alaibac M
Immunotherapy; 2019 Apr; 11(5):443-456. PubMed ID: 30786845
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicine to modulate immunotherapy in cutaneous melanoma (Review).
Volovat SR; Negru S; Stolniceanu CR; Volovat C; Lungulescu C; Scripcariu D; Cobzeanu BM; Stefanescu C; Grigorescu C; Augustin I; Lupascu Ursulescu C; Volovat CC
Exp Ther Med; 2021 May; 21(5):535. PubMed ID: 33815608
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular overview of immunotherapeutic approaches for malignant skin melanoma: Past, present and future.
Venzel R; Campos MCP; de Oliveira LP; Dan Lins RV; Siena ÁDD; Mesquita KT; Moreira Dos Santos TP; Nohata N; Arruda LCM; Sales-Campos H; Neto MPC
Crit Rev Oncol Hematol; 2023 Jun; 186():103988. PubMed ID: 37086955
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for advanced melanoma: Current knowledge and future directions.
Nakamura K; Okuyama R
J Dermatol Sci; 2016 Aug; 83(2):87-94. PubMed ID: 27302423
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive imaging in cancer immunotherapy: The way to precision medicine.
Du Y; Qi Y; Jin Z; Tian J
Cancer Lett; 2019 Dec; 466():13-22. PubMed ID: 31499119
[TBL] [Abstract][Full Text] [Related]
13. Functionalization of Nanomaterials and Their Application in Melanoma Cancer Theranostics.
Madamsetty VS; Paul MK; Mukherjee A; Mukherjee S
ACS Biomater Sci Eng; 2020 Jan; 6(1):167-181. PubMed ID: 33463233
[TBL] [Abstract][Full Text] [Related]
14. Nanomaterial-Driven Precision Immunomodulation: A New Paradigm in Therapeutic Interventions.
Aljabali AAA; Obeid MA; Gammoh O; El-Tanani M; Mishra V; Mishra Y; Kapre S; Srivatsa Palakurthi S; Hassan SS; Nawn D; Lundstrom K; Hromić-Jahjefendić A; Serrano-Aroca Á; Redwan EM; Uversky VN; Tambuwala MM
Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893150
[TBL] [Abstract][Full Text] [Related]
15. A Commotion in the Skin: Developing Melanoma Immunotherapies.
Brenner E; Röcken M
J Invest Dermatol; 2022 Aug; 142(8):2055-2060. PubMed ID: 35339277
[TBL] [Abstract][Full Text] [Related]
16. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for skin cancer.
Paulson KG; Lahman MC; Chapuis AG; Brownell I
Int Immunol; 2019 Jul; 31(7):465-475. PubMed ID: 30753483
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of melanoma: current status and prospects for the future.
Irie RF; DeNunzio FD
J Dermatol; 1993 Feb; 20(2):65-73. PubMed ID: 8478488
[TBL] [Abstract][Full Text] [Related]
19. Image-based response assessment during immunotherapy in skin cancer.
Mayer KE; Gaa J; Biedermann T; Posch C
J Dtsch Dermatol Ges; 2023 Feb; 21(2):107-114. PubMed ID: 36748647
[TBL] [Abstract][Full Text] [Related]
20. [Cancer Immunoediting in the Development of Cancer Immunotherapy].
Ariyasu R; Nishikawa H
Gan To Kagaku Ryoho; 2019 Mar; 46(3):407-411. PubMed ID: 30914573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
